202 related articles for article (PubMed ID: 23374249)
1. Topical therapies for the treatment of localized plaque psoriasis in primary care: a cost-effectiveness analysis.
Sawyer L; Samarasekera EJ; Wonderling D; Smith CH
Br J Dermatol; 2013 May; 168(5):1095-105. PubMed ID: 23374249
[TBL] [Abstract][Full Text] [Related]
2. Topical therapies for the treatment of plaque psoriasis: systematic review and network meta-analyses.
Samarasekera EJ; Sawyer L; Wonderling D; Tucker R; Smith CH
Br J Dermatol; 2013 May; 168(5):954-67. PubMed ID: 23413913
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate compared with commonly used topical treatments in the management of moderately severe plaque psoriasis in Scotland.
Bottomley JM; Auland ME; Morais J; Boyd G; Douglas WS
Curr Med Res Opin; 2007 Aug; 23(8):1887-901. PubMed ID: 17610804
[TBL] [Abstract][Full Text] [Related]
4. Pharmacoeconomic model of topical treatment options of mild to moderate psoriasis vulgaris in Germany.
Augustin M; Radtke M; van Engen A; Ruedig C; Lapp C; Moehling U
J Dtsch Dermatol Ges; 2009 Apr; 7(4):329-38. PubMed ID: 19243481
[TBL] [Abstract][Full Text] [Related]
5. Topical long-term therapy of psoriasis with vitamin D₃ analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice.
Augustin M; Mrowietz U; Bonnekoh B; Rosenbach T; Thaçi D; Reusch M; Ardabili M; Reich K
J Dtsch Dermatol Ges; 2014 Aug; 12(8):667-82. PubMed ID: 25039309
[TBL] [Abstract][Full Text] [Related]
6. The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
Freeman K
Curr Med Res Opin; 2011 Jan; 27(1):197-203. PubMed ID: 21142834
[TBL] [Abstract][Full Text] [Related]
7. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council.
van de Kerkhof PC; Kragballe K; Segaert S; Lebwohl M;
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1130-9. PubMed ID: 21564329
[TBL] [Abstract][Full Text] [Related]
8. Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients.
Shireman TI; Almehmi A; Wetmore JB; Lu J; Pregenzer M; Quarles LD
Am J Kidney Dis; 2010 Dec; 56(6):1108-16. PubMed ID: 20951487
[TBL] [Abstract][Full Text] [Related]
9. [Topical corticosteroids and corticosteroid sparing therapy in psoriasis management].
Sukarovska BG; Lipozencić J; Vrzogić P
Acta Med Croatica; 2007 Sep; 61(4):375-81. PubMed ID: 18044472
[TBL] [Abstract][Full Text] [Related]
10. Biological therapies for the treatment of severe psoriasis in patients with previous exposure to biological therapy: a cost-effectiveness analysis.
Sawyer LM; Wonderling D; Jackson K; Murphy R; Samarasekera EJ; Smith CH
Pharmacoeconomics; 2015 Feb; 33(2):163-77. PubMed ID: 25526841
[TBL] [Abstract][Full Text] [Related]
11. Clinical and cost-effectiveness of once-daily versus more frequent use of same potency topical corticosteroids for atopic eczema: a systematic review and economic evaluation.
Green C; Colquitt JL; Kirby J; Davidson P; Payne E
Health Technol Assess; 2004 Nov; 8(47):iii,iv, 1-120. PubMed ID: 15527669
[TBL] [Abstract][Full Text] [Related]
12. Are topical keratolytic agents needed in the treatment of scalp psoriasis?
Shokeen D; O'Neill JL; Taheri A; Feldman SR
Dermatol Online J; 2014 Mar; 20(3):. PubMed ID: 24656276
[TBL] [Abstract][Full Text] [Related]
13. Patterns of vitamin D analog use for the treatment of psoriasis.
Ahn CS; Awadalla F; Huang KE; Yentzer B; Dabade TS; Feldman SR
J Drugs Dermatol; 2013 Aug; 12(8):906-10. PubMed ID: 23986164
[TBL] [Abstract][Full Text] [Related]
14. Shoulder acute pain in primary health care: is retraining GPs effective? The SAPPHIRE randomized trial: a cost-effectiveness analysis.
McKenna C; Bojke L; Manca A; Adebajo A; Dickson J; Helliwell P; Morton V; Russell I; Torgerson D; Watson J
Rheumatology (Oxford); 2009 May; 48(5):558-63. PubMed ID: 19258378
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of inhaled corticosteroids for chronic obstructive pulmonary disease according to disease severity.
Sin DD; Golmohammadi K; Jacobs P
Am J Med; 2004 Mar; 116(5):325-31. PubMed ID: 14984818
[TBL] [Abstract][Full Text] [Related]
16. Topical treatments for chronic plaque psoriasis.
Mason AR; Mason J; Cork M; Dooley G; Edwards G
Cochrane Database Syst Rev; 2009 Apr; (2):CD005028. PubMed ID: 19370616
[TBL] [Abstract][Full Text] [Related]
17. Cost effectiveness of the two-compound formulation calcipotriol and betamethasone dipropionate gel in the treatment of scalp psoriasis in Scotland.
Affleck AG; Bottomley JM; Auland M; Jackson P; Ryttov J
Curr Med Res Opin; 2011 Jan; 27(1):269-84. PubMed ID: 21142836
[TBL] [Abstract][Full Text] [Related]
18. Emerging topical treatments for psoriasis.
Kivelevitch DN; Hebeler KR; Patel M; Menter A
Expert Opin Emerg Drugs; 2013 Dec; 18(4):523-32. PubMed ID: 24274614
[TBL] [Abstract][Full Text] [Related]
19. Topical treatments for scalp psoriasis: summary of a Cochrane Systematic Review.
Schlager JG; Rosumeck S; Werner RN; Jacobs A; Schmitt J; Schlager C; Nast A
Br J Dermatol; 2017 Mar; 176(3):604-614. PubMed ID: 27312814
[TBL] [Abstract][Full Text] [Related]
20. Topical management of psoriasis - corticosteroids and sparing corticosteroid therapy.
Gorgievska Sukarovska B; Lipozencić J
Acta Dermatovenerol Croat; 2006; 14(3):188-96. PubMed ID: 17010269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]